ETView Medical, Ltd., and Medutech S.A. DE C.V., ( Medutech), executed distribution agreement
The agreement enables Medutech to market ETView's VivaSight™ airway management platform in Mexico.
(April 9 2012 Tel Aviv, Israel) ETView Medical Ltd. (TASE: ETVW) announced today that it has entered into a distribution agreement with Medutech Co., Ltd. (Medutech). The agreement enables Medutech to market ETView's VivaSight™ airway management platform (previously known as TVT™), combining an airway ventilation tube with integrated continuous high resolution airway imaging for patient airway control and lung isolation capability in Mexico for a period of 2 years. Other terms were not disclosed.
William Edelman, CEO of ETView Medical commented, “We are excited to add Medutech to our expanding distributor network.” Mr. Edelman continued, “VivaSight™ is currently being distributed across Europe, Asia and the United States. VivaSight™ provides best-in-class airway management solutions for sophisticated thoracic surgical procedures requiring lung isolation.”
On March 19, 2012, announced a distribution agreement with Amphar b.v., a medical device and generic pharmaceutical distributor in the Netherlands.
On March 12, 2012, ETView announced KFDA Pre-Market Clearance for the VivaSight™‐SL line of Innovative Airway Devices
On March 5, 2012 and February 6, 2012, ETView announced filing of a Technical File, initiating CE Registration and a Pre‐Marketing Notification Application (510(k)) with the FDA for the Viva™ EB Line of Innovative Endobronchial Blockers. On December 12, 2011, ETView announced that the company filed a pre-Marketing Notification Application (510(k)) with the FDA for the VIVASIGHT™ DL Airway Management System. VivaSight™-DL1 is a proprietary, single-use disposable medical device, consisting of a dual lumen airway ventilation tube with an integrated continuous high resolution video airway imaging system permitting airway control and lung isolation during certain surgical procedures.
On February 7, and February 2, 2012, ETView announced distribution agreements with NeuroMed Ltd. (NeuroMed) a surgical products sales and distribution company based in St. Petersburg, Russia, and State of the Art (SOTA) Medical Products, Inc., a specialty surgical products sales and distribution company, based in Cedar Grove, New Jersey.
About Medutech Ltd.:
According to information provided to the company, Medutech S.A. DE C.V., Ltd., was founded in 2006. Medutech currently markets and distributes medical devices focused on airways management. Headquartered in Mexico City, Medutech focuses on business development and regional country wide marketing via a network of clinical support staff and experienced sales executives. Medutech provides extensive in-hospital training for a variety of airway management products, including laryngoscopes, laryngeal masks and bronchoscopy.
About ETView, Medical, Ltd.
ETView Medical Ltd. (TASE: ETVW) has successfully combined airway management with continuous direct airway visualization for medical professionals. ETView's patented VivaSight™- SL, a single-use disposable medical device, consisting of a single lumen ventilation tube with an integrated continuous high resolution video imaging system is currently sold in Europe, Israel, and the US to overcome current limitations and associated adverse surgical events during lung isolation surgeries.2 It is estimated that over 1.9 million lung isolation procedures are conducted worldwide annually,3 accounting for over $250mm in single-use medical disposables.4
The Company estimations in this press release, including those estimations regarding the Company's predicted scope of business, constitute forward-looking statements, as such term is defined under the Israeli Securities Law (5728-1968), and there is no certainty that such estimations shall materialize. The Company's estimations are based on business assumptions, prior experience, and professional data. Due to various factors, foreseen and unforeseen, including, but not limited to, changes in market trends, competition, global or local economic conditions, and amendments of regulation, such estimations may not materialize in whole or in part, or materialize in a substantially different manner than anticipated by the Company.
1 Patent Pending
2 Anesthesiology. 2006;105:471-477.
3 National Health Statistics Reports Number 29, October 26, 2010
4 Company estimates on file